Company profile for Panbela Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing disruptive therapeutics for urgent unmet medical needs. Our current focus is on the treatment of patients with pancreatic cancer. The initial product candidate is SBP-101, a polyamine metabolic inhibitor in clinical development for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. Panbela Therapeutics, Inc. is a clini...
Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing disruptive therapeutics for urgent unmet medical needs. Our current focus is on the treatment of patients with pancreatic cancer. The initial product candidate is SBP-101, a polyamine metabolic inhibitor in clinical development for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. Panbela Therapeutics, Inc. is a clinical stage drug development company. The Company's initial programs are aimed at diseases of the pancreas, including pancreatic cancer and pancreatitis.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
712 Vista Blvd. Suite 305 Waconia, MN 55387
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/11/14/2981624/37414/en/Panbela-Provides-Business-Update-and-Reports-Q3-2024-Financial-Results.html

GLOBENEWSWIRE
14 Nov 2024

https://www.globenewswire.com/news-release/2024/10/31/2972545/37414/en/Panbela-to-Host-Third-Quarter-2024-Earnings-Conference-Call-on-November-14-2024.html

GLOBENEWSWIRE
31 Oct 2024

https://www.globenewswire.com/news-release/2024/09/24/2952105/37414/en/First-Patient-Enrolled-in-Phase-I-Program-in-STK11-Mutant-Non-Small-Cell-Lung-Cancer-at-Moffitt-Cancer-Center.html

GLOBENEWSWIRE
24 Sep 2024

https://www.globenewswire.com/news-release/2024/08/13/2929654/37414/en/Panbela-Provides-Business-Update-and-Reports-Q2-2024-Financial-Results.html

GLOBENEWSWIRE
13 Aug 2024

https://www.globenewswire.com/news-release/2024/07/30/2921403/37414/en/Panbela-to-Host-Second-Quarter-2024-Earnings-Conference-Call-on-Aug-13-2024.html

GLOBENEWSWIRE
30 Jul 2024

https://www.globenewswire.com/news-release/2024/06/24/2902915/37414/en/Panbela-Therapeutics-Announces-Third-Independent-Safety-Review-of-Phase-3-ASPIRE-Clinical-Trial-DSMB-Recommended-Continuation-with-No-Trial-Modification.html

GLOBENEWSWIRE
24 Jun 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty